We are excited to announce an open invitation for the submission of papers to our Research Topic on Mitohormesis. This article collection aims to bring together researchers, scientists, and scholars from various disciplines to explore and unravel the complexities of cellular resilience through the lens of Mitohormesis.
Research Topic Call:
Mitohormesis, a fascinating phenomenon at the intersection of mitochondrial function and hormesis, has garnered significant attention in recent years. We invite contributors to delve into diverse aspects of Mitohormesis, ranging from molecular mechanisms to potential applications in health and disease.
Topics of Interest:
- Molecular pathways involved in Mitohormesis
- Impact of Mitohormesis on cellular homeostasis
- Therapeutic implications of Mitohormesis in aging and diseases
- Experimental approaches and methodologies in studying Mitohormesis
- Cross-disciplinary perspectives on Mitohormesis research
Prospective authors are invited to submit original research papers, review articles, and case studies that contribute to the understanding of Mitohormesis. Submissions should adhere to the Journal's guidelines and be submitted through our online submission portal.
Join us in this exciting endeavor to advance our understanding of Mitohormesis and its implications for human health. We look forward to receiving your valuable contributions.
For further details and inquiries, please visit our website https://www.frontiersin.org/journals/molecular-biosciences or contact us at molecularbiosciences.submissions@frontiersin.org.
Thank you for your interest, and we anticipate your participation in making this call a resounding success.
Keywords:
mitohormesis, LONP1, ClpP, Cancer and Immunosuppression
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
We are excited to announce an open invitation for the submission of papers to our Research Topic on Mitohormesis. This article collection aims to bring together researchers, scientists, and scholars from various disciplines to explore and unravel the complexities of cellular resilience through the lens of Mitohormesis.
Research Topic Call:
Mitohormesis, a fascinating phenomenon at the intersection of mitochondrial function and hormesis, has garnered significant attention in recent years. We invite contributors to delve into diverse aspects of Mitohormesis, ranging from molecular mechanisms to potential applications in health and disease.
Topics of Interest:
- Molecular pathways involved in Mitohormesis
- Impact of Mitohormesis on cellular homeostasis
- Therapeutic implications of Mitohormesis in aging and diseases
- Experimental approaches and methodologies in studying Mitohormesis
- Cross-disciplinary perspectives on Mitohormesis research
Prospective authors are invited to submit original research papers, review articles, and case studies that contribute to the understanding of Mitohormesis. Submissions should adhere to the Journal's guidelines and be submitted through our online submission portal.
Join us in this exciting endeavor to advance our understanding of Mitohormesis and its implications for human health. We look forward to receiving your valuable contributions.
For further details and inquiries, please visit our website https://www.frontiersin.org/journals/molecular-biosciences or contact us at molecularbiosciences.submissions@frontiersin.org.
Thank you for your interest, and we anticipate your participation in making this call a resounding success.
Keywords:
mitohormesis, LONP1, ClpP, Cancer and Immunosuppression
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.